What they were paid
Amylyx Pharmaceuticals Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $117,500 | $0 | $101,078 | $0 | $218,578 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Amylyx Pharmaceuticals, Inc. DEF 14A filed April 23, 2026, accession 0001193125-26-171800, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025Amylyx Pharmaceuticals pays directors a $45,000 cash retainer and $285,000 in Stock Options.
Committees
FY2025 · as the proxy prints themAudit · Compensation · Nominating/Governance (Chair) · Science and Technology
The rest of the Amylyx Pharmaceuticals board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Bernhardt Zeiher, M.D | Independent Director | $166,078 |
| Daphne Quimi | Independent Director | $173,578 |
| Joshua Cohen | Director | $0 |
| Justin Klee | Director | $0 |
| Karen Firestone | Independent Director | $161,078 |
| Paul Fonteyne | Independent Director | $168,578 |
The full Amylyx Pharmaceuticals compensation record
free company briefThis page is one director within Amylyx Pharmaceuticals's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat